Professor Onishi Motoko from the Department of Applied Biochemistry, Department of Applied Biology, Chubu University, Japan, and others cooperated with San-ei Sucrochemical, a saccharified product company that produces glucose and other saccharification products, and found through human clinical trials that indigestible oligosaccharides possess both sugar and acid properties. "Maltobionsyra" inhibits the loss of collagen components in bones and helps maintain bone components.
About five years ago, the research team looked at the "maltonic acid" contained in honey, which people have been eating since ancient times, and evaluated its effect on maintaining bone health. In the evaluation experiment, the research team first performed cell experiments using bone marrow cells collected from mouse femurs and found that adding maltonic acid to the cells inhibited osteoclast differentiation. Then, animal experiments were conducted, and after feeding the ovariectomized postmenopausal model mice with a diet containing maltonic acid for 80 consecutive days, it was confirmed that calcium loss and bone density in the femur were significantly suppressed compared with mice fed a diet without maltonic acid. decline.
För att verifiera effekten på människokroppen genomfördes också en klinisk prövning på människa, där kvinnliga anställda i 40- till 60-årsåldern vid Chubu University intog 4 g granulat innehållande maltonsyra per dag under fyra på varandra följande veckor. Resultaten visade att utsöndringen av ben-härledda kollagenkomponenter (DPD, u-NTx, indikatorer för benresorption) i urinen hos 33 män i klimakteriet under mer än 1 år minskade signifikant jämfört med före intag av maltonsyra. , ihållande intag av maltonsyra hämmade benförlust. Dessutom är maltonsyra en svårsmält oligosackarid, så denna kliniska prövning bekräftade att maltonsyra också har effekten av att förbättra laxermedel och reglera mag-tarmtillståndet.
Flavia
Whatsapp: plus 86 18100218515
Email: sales5@konochemical.com